REWARDS Premier TLX- Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received either the Taxus Liberte or XIENCE V drug eluting stent
A follow-up survey for patients with Coronary artery disease who have received the Promus Premier drug eluting stent
Sponsor: Medstar Research Institute
Enrolling: Male and Female Patients
IRB Number: AAAO5155
U.S. Govt. ID: NCT02256527
Contact: Tamim Nazif: 212-305-7060 / tmn31@columbia.edu
Additional Study Information: The purpose of this study is to survey patients who have undergone a percutaneous coronary intervention (PCI) at Columbia University Medical Center in which the physician used a stent called the Promus Premier stent. Patients will be asked to do a brief 15-30 minute survey regarding their health since the PCI and stent implantation.
This study is closed
Investigator
Tamim Nazif, MD
Do You Qualify?
Did you undergo a PCI with Promus Premier (alone) drug eluting stent? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Tamim Nazif
tmn31@columbia.edu
212-305-7060
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE